Provexis PLC
03 November 2006
PROVEXIS PLC
('Provexis')
Sirco Distribution Gains
Provexis, the nutraceutical company that develops scientifically-proven
functional and medical foods, announces that it has extended the distribution of
its Sirco(r) heart health juice drink, securing 283 Asda outlets from 13
November. This is in addition to the recent extension of the product's high
street presence via 110 outlets of the independent specialist food retailer
Julian Graves.
Sirco is now distributed in 1,687 outlets, including outlets with 3 of the UK's
largest multiple grocers, as well as high street and independent health food
stores.
Sirco(r) contains the patented Fruitflow(r) bioactive food ingredient that
reduces blood platelet aggregation, a significant contributing factor to
thrombosis, which can cause heart attack or stroke.
Commenting on the new distribution agreement, Stephen Moon, CEO of Provexis
said:
'This is another important milestone in extending our distribution network for
our patented, scientifically-proven Sirco(r) product, in line with our business
plan. We are delighted that we have secured this agreement with another of the
UK's leading supermarket retailers.'
For further information please contact:
Stephen Moon, CEO
Provexis plc Tel: 020 8392 6634
Emma Kent/Victoria Geoghegan
Bell Pottinger Corporate & Financial Tel: 020 7861 3232
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.